These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6835036)

  • 21. Synthesis and pharmacological evaluation of a clofibrate-related tricyclic spirolactone, 5-chloro-4',5-dihydrospiro[benzofuran-2(3H),3'(2'H)-furan]-2'-one.
    Witiak DT; Cavestri RC; Newman HA; Baldwin JR; Sober CL; Feller DR
    J Med Chem; 1978 Dec; 21(12):1198-202. PubMed ID: 722728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of benzodioxane, chroman, and dihydrobenzofuran analogs of clofibrate on various parameters of hepatic drug metabolism.
    Lewis NJ; Feller DR; Poochikian GK; Witiak DT
    J Med Chem; 1974 Jan; 17(1):41-5. PubMed ID: 4808468
    [No Abstract]   [Full Text] [Related]  

  • 23. Alterations in rat serum lipids and apolipoproteins following clofibrate treatment.
    Dashti N; Ontko JA
    Atherosclerosis; 1983 Dec; 49(3):255-66. PubMed ID: 6419747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
    Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
    Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of diets rich in fermentable carbohydrates on plasma lipoprotein levels and on lipoprotein catabolism in rats.
    Mazur A; Rémésy C; Gueux E; Levrat MA; Demigné C
    J Nutr; 1990 Sep; 120(9):1037-45. PubMed ID: 2168942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The activity of 3-hydroxy-3-methylglutaryl-CoA reductase and acyl-CoA: cholesterol acyltransferase in hepatic microsomes from male, female and pregnant rats. The effect of cholestyramine treatment and the relationship of enzyme activity to microsomal lipid composition.
    Innis SM
    Biochim Biophys Acta; 1986 Feb; 875(2):355-61. PubMed ID: 3942771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of clofibrate and bezafibrate on cholesterol metabolism in the liver of the male rat.
    Shand JH; West DW
    Lipids; 1994 Nov; 29(11):747-52. PubMed ID: 7869854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of clofibrate and ethyl-5-(p-chlorophenoxy)-3-hydroxy-3-methylpentanoate induced changes in serum lipoprotein cholesterol and hepatic peroxisome proliferation in the normal rat.
    Stevens TJ; Stafford WW; Day CE; Block EM
    Artery; 1983; 12(2):81-94. PubMed ID: 6678582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of benzodioxane, chroman and dihydrobenzofuran analogs of clofibrate in a Triton hyperlipemic rat model.
    Newman HA; Heilman WP; Witiak DT
    Lipids; 1973 Jul; 8(7):378-84. PubMed ID: 4724016
    [No Abstract]   [Full Text] [Related]  

  • 30. A quantitative analysis of fine structure and drug metabolism in livers of clofibrate-treated young adult and retired breeder rats.
    Anthony LE; Schmucker DL; Mooney JS; Jones AL
    J Lipid Res; 1978 Feb; 19(2):154-65. PubMed ID: 632678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeding status-related effects of 17 beta-estradiol on liver 3-hydroxy-3-methylglutaryl CoA reductase.
    Alonso MA; Fernandez de Quincoces A; Lacort M; Gandarias JM; Ochoa B
    Exp Clin Endocrinol; 1993; 101(3):123-30. PubMed ID: 8223979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation.
    Guan JZ; Tamasawa N; Murakami H; Matsui J; Yamato K; Suda T
    Tohoku J Exp Med; 2003 Dec; 201(4):251-9. PubMed ID: 14690017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HMG-CoA reductase, cholesterol 7alpha-hydroxylase, LCAT, ACAT, LDL receptor, and SRB-1 in hereditary analbuminemia.
    Liang K; Vaziri ND
    Kidney Int; 2003 Jul; 64(1):192-8. PubMed ID: 12787409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low density lipoprotein-lowering and high density lipoprotein-elevating effects of nicardipine in rats.
    Ohata I; Sakamoto N; Nagano K; Maeno H
    Biochem Pharmacol; 1984 Jul; 33(14):2199-205. PubMed ID: 6466343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Action of clofibrate and its analogs in rats. Dissociation of hypolipidemic effects and the induction of peroxisomal beta-oxidation.
    Harrison EH
    Biochim Biophys Acta; 1984 Nov; 796(2):163-8. PubMed ID: 6541949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of clofibrate on lipoprotein metabolism in hyperlipidemic rats.
    Segal P; Roheim PS; Eder HA
    J Clin Invest; 1972 Jul; 51(7):1632-8. PubMed ID: 4338117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.
    Stanely Mainzen Prince P; Kannan NK
    J Pharm Pharmacol; 2006 Oct; 58(10):1373-83. PubMed ID: 17034661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of clofibrate on cholesterol metabolism in rats treated with polychlorinated biphenyls.
    Nakagawa M; Shimokawa T; Noguchi A; Ishihara N; Kojima S
    Lipids; 1986 Feb; 21(2):159-63. PubMed ID: 3083175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of manufactured soluble dietary fiber from Quercus mongolica on hepatic HMG-CoA reductase and lipoprotein lipase activities in epididymal adipose tissue of rats fed high cholesterol diets.
    Chai YM; Lim BK; Lee JY; Kim MN; Park MR; Rhee SJ
    J Med Food; 2003; 6(4):329-36. PubMed ID: 14977441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits.
    Azuma Y; Kawasaki T; Ikemoto K; Obata K; Ohno K; Sajiki N; Yamada T; Yamasaki M; Nobuhara Y
    Jpn J Pharmacol; 1998 Nov; 78(3):355-64. PubMed ID: 9869270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.